Middle East Healthcare Company announces the commencement of the offer and subscription in its Sukuk denominated in SAR

Middle East Healthcare Company announces the commencement of the offer and subscription in its Sukuk denominated in SAR

Institutional investors wishing to purchase the Sukuk will be required to submit a duly completed form to Al Rajhi Capital being the dealer. Retail investors will be required to submit a duly completed form to Al Rajhi Bank as the receiving agent through the available channels, including through the internet. The purchase of the Sukuk by investors is subject to satisfying the terms and conditions set out in the investor application form and the Base Prospectus. For further details about the subscription in the Sukuk, please refer to the Base Prospectus. The Company stresses the importance of reviewing the following documents carefully and in full before making any investment decision in relation to the subscription in the Sukuk: (1) the Base Prospectus; and (2) the Company’s interim condensed consolidated financial statements (unaudited) as at and for the nine-month period ended 30 September 2023. The Base Prospectus has been published on the website of the Capital Market Authority (https://cma.org.sa), the website of the Saudi Stock Exchange (Tadawul) (www.saudiexchange.sa), the website of